{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T05:36:19Z","timestamp":1697088979138},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1186\/bcr550","type":"journal-article","created":{"date-parts":[[2002,10,24]],"date-time":"2002-10-24T07:09:08Z","timestamp":1035443348000},"source":"Crossref","is-referenced-by-count":3,"title":["Estrogen\u2013progestin replacement therapy: regulatory action needed"],"prefix":"10.1186","volume":"4","author":[{"given":"Malcolm C","family":"Pike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald K","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,12,1]]},"reference":[{"key":"549_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/bcr540","volume":"4","author":"C Schairer","year":"2002","unstructured":"Schairer C: Progesterone receptors \u2013 animal models and cell signalling in breast cancer: implications for breast cancer of inclusion of progestins in hormone replacement therapies. Breast Cancer Res. 2002, 4: 244-248. 10.1186\/bcr540.","journal-title":"Breast Cancer Res"},{"key":"549_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","unstructured":"Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333. 10.1001\/jama.288.3.321.","journal-title":"JAMA"},{"issue":"suppl","key":"549_CR3","first-page":"9","volume":"49","author":"BE Henderson","year":"1988","unstructured":"Henderson BE, Pike MC, Ross RK, Mack TM, Lobo RA: Re-evaluating the role of progestogen therapy after the menopause. Fertil Steril. 1988, 49 (suppl): 9-15.","journal-title":"Fertil Steril"},{"key":"549_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0277-5379(88)90173-3","volume":"24","author":"TJA Key","year":"1988","unstructured":"Key TJA, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988, 24: 29-43. 10.1016\/0277-5379(88)90173-3.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"549_CR5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/0140-6736(92)93064-T","volume":"340","author":"I Persson","year":"1992","unstructured":"Persson I, Yuen J, Bergkvist L, Adami HO, Hoover R, Schairer C: Combined oestrogen-progestogen replacement therapy and breast cancer risk [letter]. Lancet. 1992, 340: 1044-10.1016\/0140-6736(92)93064-T.","journal-title":"Lancet"},{"key":"549_CR6","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJM199112193252514","volume":"325","author":"D Shoupe","year":"1991","unstructured":"Shoupe D, Meme D, Mezrow G, Lobo RA: Prevention of endometrial hyperplasia in postmenopausal women with intrauterine progesterone. N Engl J Med. 1991, 325: 1811-1812.","journal-title":"N Engl J Med"},{"key":"549_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0015-0282(01)02846-1","volume":"76","author":"E Varila","year":"2001","unstructured":"Varila E, Wahlstrom T, Rauramo I: A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy. Fertil Steril. 2001, 76: 969-973. 10.1016\/S0015-0282(01)02846-1.","journal-title":"Fertil Steril"},{"key":"549_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0015-0282(16)56935-0","volume":"62","author":"RA Miles","year":"1994","unstructured":"Miles RA, Paulson RJ, Lobo RA, Press MF, Dahmoush L, Sauer MV: Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes. Fertil Steril. 1994, 62: 485-490.","journal-title":"Fertil Steril"},{"key":"549_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0029-7844(97)00270-6","volume":"90","author":"R Fanchin","year":"1997","unstructured":"Fanchin R, de Ziegler D, Bergeron C, Righini C, Torrisi C, Frydman R: Transvaginal administration of progesterone. Obstet Gynecol. 1997, 90: 396-401. 10.1016\/S0029-7844(97)00270-6.","journal-title":"Obstet Gynecol"},{"key":"549_CR10","first-page":"693","volume":"83","author":"B Ettinger","year":"1994","unstructured":"Ettinger B, Selby J, Citron JT, Vangessel A, Ettinger VM, Hendrickson MR: Cyclic hormone replacement therapy using quarterly progestin. Obstet Gynecol. 1994, 83: 693-700.","journal-title":"Obstet Gynecol"},{"key":"549_CR11","first-page":"787","volume":"84","author":"DB Williams","year":"1994","unstructured":"Williams DB, Voigt BJ, Yao SF, Schoenfeld MJ, Judd HL: Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement. Obstet Gynecol. 1994, 84: 787-793.","journal-title":"Obstet Gynecol"},{"key":"549_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0039-128X(00)00122-7","volume":"65","author":"MC Pike","year":"2000","unstructured":"Pike MC, Ross RK: Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids. 2000, 65: 659-664. 10.1016\/S0039-128X(00)00122-7.","journal-title":"Steroids"},{"key":"549_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00003","volume":"130","author":"GA Greendale","year":"1999","unstructured":"Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskaas C, Bush T, Barrett-Connor E: Effects of estrogen and estrogen\u2013progestin on mammographic parenchymal density. Ann Intern Med. 1999, 130: 262-269.","journal-title":"Ann Intern Med"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/bcr550\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T06:59:17Z","timestamp":1484722757000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["549"],"URL":"https:\/\/doi.org\/10.1186\/bcr550","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]},"article-number":"222"}}